Intravenous Immunoglobulins for the Treatment of Covid-19 Patients: a Clinical Trial
NCT04548557
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
BIOLOGICAL:
intravenous immunoglobulin therapy
Sponsor
University of Health Sciences Lahore
Collaborators
[object Object]
[object Object]